{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:21:57Z","timestamp":1788956517378,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nanomaterial-based therapies have emerged as a promising approach for ulcerative colitis (UC). To systematically map the field, we performed a bibliometric analysis of research over the past 25 years, aiming to reveal knowledge evolution, core themes, and emerging trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched the Web of Science Core Collection and Scopus for English-language publications (2001\u20132025) using the keywords \u201cnanomaterials\u201d and \u201culcerative colitis\u201d including original articles and reviews. After deduplication, 1,316 publications were analyzed using CiteSpace, HistCite, and R to construct collaboration networks, keyword co-occurrence maps, co-citation networks, and thematic evolution analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>UC-focused nanotherapeutics show sustained growth and increasing international collaboration, with China as the leading contributor. Analysis identified 57 subject categories, 537 keywords, and 899 publications with citation bursts. Five emerging themes were highlighted: gut microbiota, reactive oxygen species, NLRP3 inflammasome, drug delivery systems, and polymeric nanoparticles. Nanotechnology is increasingly integrated into UC pathogenesis studies, with a shift from passive drug delivery toward intelligent, mechanism-driven, and combination therapies. Co-citation analysis identified seven core areas, including inflammation regulation, targeted delivery, immune modulation, hydrogel carriers, and nanotherapeutics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study maps the evolving landscape of UC nanotherapeutics, highlighting the field\u2019s shift toward precise, intelligent, and mechanism-guided strategies. Future research should emphasize nanodesign, safety evaluation, and personalized therapies, facilitating translational innovation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1739037","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:56:57Z","timestamp":1771397817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Structural and temporal dynamics of nano-based therapies in ulcerative colitis: history, hotspots, and emerging trends"],"prefix":"10.3389","volume":"17","author":[{"given":"Junzu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.gastro.2017.05.018","article-title":"Understanding and preventing the global increase of inflammatory bowel disease","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2020.07.005","article-title":"Epidemiology and pathogenesis of ulcerative colitis","volume":"49","author":"Du","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2022.2081453","article-title":"Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes","volume":"38","author":"Pandey","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"B5","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","article-title":"Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments","volume":"45","author":"Wangchuk","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.12.074","article-title":"Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease","volume":"558","author":"Zeeshan","year":"2019","journal-title":"Int J Pharm"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1088\/2057-1976\/acedb2","article-title":"Nano-based drug delivery system for therapeutics: a comprehensive review","volume":"9","author":"Prakash","year":"2023","journal-title":"BioMed Phys Eng Express"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i40.11343","article-title":"Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease","volume":"21","author":"Takedatsu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-00927-x","article-title":"Advancement of nanomedicines in chronic inflammatory disorders","volume":"30","author":"Jogpal","year":"2022","journal-title":"Inflammopharmacology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3382360","article-title":"Global trends in research of treatment on bladder cancer with chinese medicine monomer from 2000 to 2021: A bibliometric analysis","volume":"2022","author":"Li","year":"2022","journal-title":"J Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2024.01.017","article-title":"Structural and temporal dynamics analysis of zinc-based biomaterials: History, research hotspots and emerging trends","volume":"35","author":"Yuan","year":"2024","journal-title":"Bioact Mater"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1677552","article-title":"Immune and inflammatory mechanisms in asthma: insights into epigenetic modifications","volume":"16","author":"Fan","year":"2025","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12585","article-title":"Treatment options for refractory ulcerative colitis: Small molecules, big effects","volume":"12","author":"Marafini","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-020-01219-0","article-title":"Advances in colon-targeted nano-drug delivery systems: challenges and solutions","volume":"43","author":"Naeem","year":"2020","journal-title":"Arch Pharm Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7150\/thno.37593","article-title":"Micro\/nano-bubble-assisted ultrasound to enhance the EPR effect and potential theranostic applications","volume":"10","author":"Duan","year":"2020","journal-title":"Theranostics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.02.017","article-title":"Reactive oxygen species-responsive nanocarrier ameliorates murine colitis by intervening colonic innate and adaptive immune responses","volume":"31","author":"Yan","year":"2023","journal-title":"Mol Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.117998","article-title":"Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment","volume":"263","author":"Luo","year":"2021","journal-title":"Carbohydr Polym"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e2300601","DOI":"10.1002\/advs.202300601","article-title":"A curcumin-modified coordination polymers with ROS scavenging and macrophage phenotype regulating properties for efficient ulcerative colitis treatment","volume":"10","author":"Yao","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cppeds.2014.10.003","article-title":"Inflammatory bowel disease: the classic gastrointestinal autoimmune disease","volume":"44","author":"Kaistha","year":"2014","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7150\/thno.87739","article-title":"Targeted modulation of intestinal epithelial regeneration and immune response in ulcerative colitis using dual-targeting bilirubin nanoparticles","volume":"14","author":"Zhuo","year":"2024","journal-title":"Theranostics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109251","article-title":"Luteolin alleviates ulcerative colitis by restoring the balance of NCR-ILC3\/NCR+ILC3 to repairing impaired intestinal barrier","volume":"112","author":"Xie","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2058646","article-title":"Application of chitosan\/alginate nanoparticle in oral drug delivery systems: prospects and challenges","volume":"29","author":"Li","year":"2022","journal-title":"Drug Deliv"},{"key":"B25","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1186\/s12967-024-05682-x","article-title":"Berberine-loaded PLGA nanoparticles alleviate ulcerative colitis by targeting IL-6\/IL-6R axis","volume":"22","author":"Liu","year":"2024","journal-title":"J Transl Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415527","article-title":"Synthesis, characterization of low molecular weight chitosan selenium nanoparticles and its effect on DSS-induced ulcerative colitis in mice","volume":"23","author":"Peng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121707","article-title":"Oral delivery of IL-22 mRNA-loaded lipid nanoparticles targeting the injured intestinal mucosa: A novel therapeutic solution to treat ulcerative colitis","volume":"288","author":"Sung","year":"2022","journal-title":"Biomaterials"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ph13090255","article-title":"Eluxadoline loaded solid lipid nanoparticles for improved colon targeting in rat model of ulcerative colitis","volume":"13","author":"Anwer","year":"2020","journal-title":"Pharm (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbae122","article-title":"Curcumin-incorporated EGCG-based nano-antioxidants alleviate colon and kidney inflammation via antioxidant and anti-inflammatory therapy","volume":"11","author":"Pan","year":"2024","journal-title":"Regener Biomater"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116538","article-title":"Modified Gegen Qinlian decoction ameliorated ulcerative colitis by attenuating inflammation and oxidative stress and enhancing intestinal barrier function in vivo and in vitro","volume":"313","author":"Wang","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1217165","article-title":"Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease","volume":"14","author":"Sahoo","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102441","article-title":"Mo3Se4 nanoparticle with ROS scavenging and multi-enzyme activity for the treatment of DSS-induced colitis in mice","volume":"56","author":"Guo","year":"2022","journal-title":"Redox Biol"},{"key":"B33","article-title":"Ascorbic acid ameliorates oxidative stress and inflammation in dextran sulfate sodium-induced ulcerative colitis in mice","volume":"8","author":"Yan","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.4c13100","article-title":"Eliminating ROS and alleviating inflammation to restore the integrity of intestinal epithelium in DSS-induced ulcerative colitis by a pH-responsive delivery system of curcumin","volume":"73","author":"Li","year":"2025","journal-title":"J Agric Food Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12849","article-title":"Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment","volume":"21","author":"Guo","year":"2020","journal-title":"J Dig Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e2103189","DOI":"10.1002\/advs.202103189","article-title":"Modulation of gut barrier functions in ulcerative colitis by hyaluronic acid system","volume":"9","author":"Kotla","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c04569","article-title":"Nanocrystalline cellulose modulates dysregulated intestinal barriers in ulcerative colitis","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102118","article-title":"Hyaluronic acid-conjugated PLGA nanoparticles alleviate ulcerative colitis via CD44-mediated dual targeting to inflamed colitis tissue and macrophages","volume":"14","author":"Hlaing","year":"2022","journal-title":"Pharmaceutics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7150\/thno.15710","article-title":"Combination therapy for ulcerative colitis: orally targeted nanoparticles prevent mucosal damage and relieve inflammation","volume":"6","author":"Xiao","year":"2016","journal-title":"Theranostics"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01299-8","article-title":"All-in-one theranostic nano-platform based on polymer nanoparticles for BRET\/FRET-initiated bioluminescence imaging and synergistically anti-inflammatory therapy for ulcerative colitis","volume":"20","author":"Yan","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12951-024-02725-9","article-title":"Enzyme\/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating","volume":"22","author":"Shi","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"120884","DOI":"10.1016\/j.carbpol","article-title":"Hyaluronic acid modified oral drug delivery system with mucoadhesiveness and macrophage-targeting for colitis treatment","volume":"313","author":"Zhang","year":"2023","journal-title":"Carbohydr Polym"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001233","article-title":"Oral nano vitamin D supplementation reduces disease activity in ulcerative colitis: A double-blind randomized parallel group placebo-controlled trial","volume":"53","author":"Ahamed","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s43556-024-00207-w","article-title":"Ulcerative colitis: molecular insights and intervention therapy","volume":"5","author":"Liang","year":"2024","journal-title":"Mol Biomed"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.691480","article-title":"Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice","volume":"12","author":"Bruscoli","year":"2021","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"eado7438","DOI":"10.1126\/sciadv.ado7438","article-title":"Two-birds-one-stone\" oral nanotherapeutic designed to target intestinal integrins and regulate redox homeostasis for UC treatment","volume":"10","author":"Huang","year":"2024","journal-title":"Sci Adv"},{"key":"B48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7150\/thno.118236","article-title":"Multifunctional macrophage mimetic nanoplatform modulates vascular and epithelial double gut barriers to alleviate ulcerative colitis","volume":"16","author":"Cheng","year":"2026","journal-title":"Theranostics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1739037\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:56:58Z","timestamp":1771397818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1739037\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2026.1739037"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1739037","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1739037"}}